Mode
Text Size
Log in / Sign up
N/A N=846

Effects of 12-week Digital Treatment in Patients With Hand OA on Pain and Function

Hand Osteoarthritis · Wrist Osteoarthritis · Thumb Osteoarthritis · Finger Osteoarthritis

Enrolled (actual)
846
Serious AEs
Results posted
Aug 2025
Primary outcome: Primary: Change in Pain Intensity (Numerical Rating Scale NRS, Discrete Boxes 0-10, Higher Score Mean Worse Pain) — -1.30 Units on a scale

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Joint Academy digital treatment (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Joint Academy
Primary completion
Jul 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Pain Intensity (Numerical Rating Scale NRS, Discrete Boxes 0-10, Higher Score Mean Worse Pain)
-1.30
SECONDARY
Functional Index for Hand OsteoArthritis (FIHOA 0 - 30 Higher Score Means Worse Outcome)
-0.81

Summary

The purpose of this study is to evaluate the effect of a 12 week digital treatment program for patients with hand osteoarthritis. The treatment consisted of exercises and educational sessions with respect to the disease, its natural course and recommended treatment strategies. Design: An observational longitudinal cohort study. The investigators will include participants who participated in the digital treatment of Joint Academy® for 3 months. Outcomes: Investigators will analyze pain with Numeric Rating Scale (NRS) 0-10 (best to worst), function with the Functional Index for Hand OsteoArthritis (FIHOA) and health related quality of life with EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) at baseline and at 3 months. Main outcome will be change in pain. The investigators will also analyze minimally clinical important changes (improved or not) and mean changes in EQ-5D-5L index score, pain and function.

Eligibility Criteria

Inclusion Criteria

  • Older than 18 years (often much older)
  • Previous physical examination regarding hand symptoms
  • Long-lasting hand pain where osteoarthritis is suspected l(for example joint-specific load and/or rest pain, impaired function with stiffness, decreased grip strength, clumsiness, bone roughening of joints).
  • started the treatment between 2022-XX-XX to 2022-XX-XX

Exclusion Criteria

  • Pregnancy
  • Tendon disease (trigger finger, tendinopathy)
  • Nerve entrapment
  • Arthritis
  • Acute injuries (fracture and/or distortion)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05499559). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search